Bain Capital To Bet Big On Life Sciences Real Estate, Again
Boston-based Bain Capital is located in the center of the life sciences market and related real estate deals, so it’s no surprise the firm has invested heavily in such properties. And now it’s supercharging its investments in the sector, according to the Boston Business Journal, one of many signs of the big pandemic-era boost bringing more investment and development to the space.
Bain plans to create a new fund focused on the life sciences real estate sector, a securities filing by the company earlier this week revealed. There are no fundraising targets for the new venture, the report noted, but for the sake of comparison, the firm’s 2019 real estate fund raised $1.5B and the 2016 fund hit $720M.
Bain had invested in 5M SF of life sciences property, especially in the Boston market, by the end of last year. The firm has also invested in Bay Area projects, such as the recently announced Genesis Marina project.
Life sciences investment jumped 36.1% nationally in 2020, hitting a record $29.9B despite the coronavirus pandemic, according to a Newmark Group report from January.
